SR604 is named as a drug or biological intervention in 3 clinical trials in our China and USA trial registers, 3 of which are recruiting. Lead sponsors include Shanghai RAAS Blood Products Co., Ltd. (2) and Equilibra Bioscience LLC (1). Registered phases: Phase 1, Phase 1/2 and Phase 2. Conditions studied include Hemophilia A; Hemophilia B; Factor VII Deficiency.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07640893 | A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease (ClinicalTrials.gov ↗) Von Willebrand Disease (VWD) |
Phase 2 | Recruiting |
| NCT07644832 | An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency (ClinicalTrials.gov ↗) Hemophilia A, Hemophilia B, Factor VII Deficiency |
Phase 1/2 | Recruiting |
| NCT06349473 | A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency) (ClinicalTrials.gov ↗) Healthy Participants, Hemophilia A, Hemophilia B |
Phase 1 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Hemophilia A | 2 |
| Hemophilia B | 2 |
| Factor VII Deficiency | 2 |
| Healthy Participants | 1 |
| Von Willebrand Disease (VWD) | 1 |
| Lead sponsor | Trials |
|---|---|
| Shanghai RAAS Blood Products Co., Ltd. | 2 |
| Equilibra Bioscience LLC | 1 |
| Register | SR604 trials |
|---|---|
| Clinical trials in China | 2 |
| Clinical trials in USA | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how SR604 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists SR604 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.